bioRxivCancer BiologyPreprint
VISTA-induced tumor suppression by a four amino acid intracellular motif
Yan Zhao, Tina Andoh, Fatima CharlesiD, Priyanka ReddyiD, Kristina PauliD, Harsh GoariD, Ishrat DurdanaiD, Caiden J. GolderiD, Ashley Hardy, Marisa M. JuntillaiD, Soo‐Ryum YangiD, Chieh‐Yu LiniD, Idit Sagiv-BarfiiD, Benjamin S. GelleriD, Stephen Moore, Dipti ThakkariD, Jerome Douglas Boyd-KirkupiD, Yan Shen PengiD, James M. FordiD, Melinda L. TelliiD, Song ZhangiD, Allison W. KurianiD, Robert B. WestiD, Tao YueiD, Andrew M. LipchikiD, , Joshua James GruberiD
Abstract
VISTA is a key immune checkpoint receptor under investigation for cancer immunotherapy; however, its signaling mechanisms remain unclear. Here we identify a conserved four amino acid (NPGF) intracellular motif in VISTA that suppresses cell proliferation by constraining cell-intrinsic growth receptor signaling. The NPGF motif binds to the adapter protein NUMB and recruits Rab11 endosomal recycling machinery. We identify and characterize a class of triple-negative breast cancers with high VISTA expression and low proliferative index. In tumor cells with high VISTA levels, the NPGF motif sequesters NUMB at endosomes, which interferes with epidermal growth factor receptor (EGFR) trafficking and signaling to suppress tumor growth. These effects do not require canonical VISTA ligands, nor a functioning immune system. As a consequence of VISTA expression, EGFR receptor remains abnormally phosphorylated and cannot propagate ligand-induced signaling. Mutation of the VISTA NPGF domain reverts VISTA-induced growth suppression in multiple breast cancer mouse models. These results define a mechanism by which VISTA represses NUMB to control malignant epithelial cell growth and signaling. They also define distinct intracellular residues that are critical for VISTA-induced cell-intrinsic signaling that could be exploited to improve immunotherapy.
- organism: human
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: genetic perturbation / CRISPR
- Citations
- 7
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Expression of immune checkpoint VISTA represents a differentiated state of cancer cells and plays a role in regulating actin cytoskeleton
- Structure and Functional Binding Epitope of V-domain Ig Suppressor of T-cell Activation (VISTA)
N. Mehta, S. Maddineni, … J. R. Cochran·bioRxiv·Apr 3, 2019
- Tumor expressed CD95 causes suppression of anti-tumor activity of NK cells in a model of triple negative breast cancer
A. S. Qadir, J. P. Guegan, … M. E. Peter·bioRxiv·Feb 12, 2021
- Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand
- Inhibition of EMT driver PTK6 enhances anti-tumor immune responses against triple-negative breast cancer
Ibuki Harada, Criseyda Martinez, … Hanna Yoko Irie·bioRxiv·Jan 11, 2025
- Antibodies blocking PlGF or VEGF interactions with the NRP1 receptormediate anti-proliferative effects
Samuel A. Blackman, Ahlam N. Qerqez, … Jennifer A. Maynard·Journal of Biological ChemistryPeer-reviewed·Apr 17, 2026